C25 -Malignant neoplasm of pancreas
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C25 – N =36,422
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1995 | 7.5% | 2.9% | 7.7% | 38.4% | 43.5% | 1,428 |
1996 | 6.4% | 2.9% | 7.4% | 35.6% | 47.6% | 1,570 |
1997 | 5.8% | 2.5% | 7% | 36.3% | 48.4% | 1,594 |
1998 | 7.2% | 3.5% | 7.2% | 37.6% | 44.5% | 1,617 |
1999 | 5.8% | 2.5% | 5.8% | 40.3% | 45.6% | 1,507 |
2000 | 6.2% | 3.1% | 6.8% | 39.2% | 44.7% | 1,608 |
2001 | 3.6% | 3.6% | 5.8% | 45.4% | 41.7% | 1,600 |
2002 | 4.5% | 3.4% | 7.2% | 43.9% | 41.1% | 1,705 |
2003 | 3.6% | 3.7% | 8.4% | 45.3% | 38.9% | 1,730 |
2004 | 3.1% | 4.7% | 7.7% | 46.3% | 38.1% | 1,694 |
2005 | 4% | 8.4% | 4.6% | 36% | 47.1% | 1,832 |
2006 | 4% | 11.1% | 6.4% | 45.4% | 33.2% | 1,927 |
2007 | 4.3% | 9.8% | 6.2% | 51% | 28.7% | 1,978 |
2008 | 5% | 13.6% | 7% | 53.3% | 21.1% | 1,967 |
2009 | 4.8% | 13.7% | 8.6% | 54.8% | 18.2% | 1,993 |
2010 | 5.2% | 14.5% | 8.8% | 54.7% | 16.9% | 2,100 |
2011 | 5.3% | 12.8% | 7% | 43.5% | 31.5% | 2,208 |
2012 | 4.8% | 11.4% | 6.3% | 37.4% | 40% | 2,056 |
2013 | 5.4% | 11.5% | 7% | 42.9% | 33.2% | 2,117 |
2014 | 5.8% | 14.5% | 10.1% | 46% | 23.6% | 2,191 |